Age-Related Decline Of Platelet-Derived Growth Factor Receptor Alpha In Mesenchyme Surrounding Meibomian Gland Leads To Meibomian Gland Dysfunction
Our eyes rely on tiny oil glands in our eyelids, called meibomian glands, to produce a special oil known as meibum. This meibum forms a protective layer over our tears, preventing them from evaporating too quickly and keeping our eyes moist and comfortable. When these glands don’t work as they should, it leads to a common condition called meibomian gland dysfunction (MGD), which is a major cause of dry eye syndrome, causing discomfort, redness, and sometimes blurry vision.
As we get older, our bodies naturally change, and our meibomian glands are affected too. Recent research suggests that a significant part of this age-related decline is linked to the supportive tissue around these glands, known as the mesenchyme. This mesenchyme contains cells that respond to growth signals through specific receptors, such as the platelet-derived growth factor receptor alpha (PDGFRα). Think of PDGFRα as a receiver that picks up messages telling the surrounding cells to maintain and repair the gland tissue.
Scientists have discovered that with age, there’s a reduction in these crucial PDGFRα receptors in the mesenchyme. This decrease means the cells in the supportive tissue receive fewer vital signals, leading to a weakening of the gland’s support system and, consequently, its impaired function. This deterioration contributes to the development and worsening of dry eye symptoms in older individuals. Understanding this specific mechanism opens doors for developing new treatments that could target these age-related cellular changes to help restore the health and function of our meibomian glands.
Source: link to paper